Market Overview

Why Co-Diagnostics Stock Is Trading Higher Today

Why Co-Diagnostics Stock Is Trading Higher Today

Co-Diagnostics (NASDAQ: CODX) shares are trading higher on Thursday after the company announced its Logix Smart ABC Test is anticipated to be ready for launch to U.S. CLIA laboratory customers the first week of October.

Co-Diagnostics is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). 

Co-Diagnostics shares were trading up 5.58% at $14.20 at the time of publication. The stock has a 52-week high of $30.99 and a 52-week low of 85 cents.


Related Articles (CODX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at